Symbiotec Pharmalab Share Price
03 Nov, 2026 12:41 PM (IST)
Symbiotec Pharmalab Performance
- Today's Low
- ₹1,213
- Today's High
- ₹1,268
- 52 Week Low
- ₹934
- 52 Week High
- ₹1,310
- Open Price₹1,229
- Previous Close₹1,225
- Volume207,727
- 50 DMA-
- 100 DMA-
- 200 DMA-
Symbiotec Pharmalab Chart
Investment Returns
- Over 1 Month + 5.38%
- Over 3 Month + 27.78%
- Over 6 Month + 27.78%
- Over 1 Year + 27.78%
Smart Investing Starts Here Start SIP with Symbiotec Pharmalab for Steady Growth!
Symbiotec Pharmalab Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -
- PEG Ratio
- -
- Market Cap Cr
- 8,112
- P/B Ratio
- 7.1
- Average True Range
- 61.3
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 34.8
- RSI
- 54.59
- MFI
- 77.93
Latest Stock News Updates
Earnings Conference Call / Analysts Meet to discuss the financial performance and business updates for the quarter and half year ended September 30, 2026 (Q2FY27). The Earnings Conference Call is scheduled to be held on Friday, November 06, 2026 at 09:30 A.M. IST, through virtual/audio conference call. The call is being hosted by Avendus Spark. The schedule of the aforesaid call is subject to change due to exigencies, if any. Kindly note that no unpublished price sensitive information shall be shared during the call. The above information is also being made available on the website of the Company at investor.symbiotec.com
- BSE India
- 5 days 18 hours ago
Symbiotec Pharmalab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve To consider and approve the Unaudited Standalone and Consolidated Financials Results for the quarter and half year ended September 30, 2026 along with Limited Review Report.
- BSE India
- 5 days 19 hours ago
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 16, 2026 for Anil Satwani, Sushil Satwani, Kashish Satwani, Satwani Holdings LLP, Kashish and Anil Satwani Family Trust, Arjun Anil Satwani Family Trust & Krishna Anil Satwani Family Trust
- BSE India
- 2 weeks 3 days ago
Symbiotec Pharmalab Financials
Symbiotec Pharmalab Technicals
EMA & SMA
- Bearish Moving Average 0
- Bullish Moving Average 9
- 20 Day
- ₹1,205.80
- 50 Day
- -
- 100 Day
- -
- 200 Day
- -
Resistance and Support
- R3 1,287.20
- R2 1,273.10
- R1 1,249.10
- S1 1,211.00
- S2 1,196.90
- S3 1,172.90
Symbiotec Pharmalab Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-11-05 | Quarterly Results | |
| 2026-09-21 | Quarterly Results |
About Symbiotec Pharmalab
Symbiotec Pharmalab are a research and development-driven, science-based pharmaceutical and biotechnology company with capabilities across three platforms- organic chemistry, biotechnology and complex injectables. View More- NSE Symbol
- SYMBIOTEC
- BSE Symbol
- 544889
- ISIN
- INE899I01028
Similar Stocks to Symbiotec Pharmalab
Popular Stocks
Symbiotec Pharmalab FAQs
Symbiotec Pharmalab share price is ₹1,262 As on 03 November, 2026 | 12:29
The Market Cap of Symbiotec Pharmalab is ₹8112.3 Cr As on 03 November, 2026 | 12:29
The P/E ratio of Symbiotec Pharmalab is As on 03 November, 2026 | 12:29
The PB ratio of Symbiotec Pharmalab is 7.1 As on 03 November, 2026 | 12:29
The 52 week High & Low of Symbiotec Pharmalab is ₹1309.9/₹934.2 respectively As on 03 November, 2026 | 12:29
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.